The Bureau of Economic Analysis released its monthly trade data for March, and despite it being the first full month of the imbroglio in the Strait of Hormuz, imports rose more than exports and the deficit surpassed the three month moving average.
Without secure upstream API and 6-APA production, the United States does not have true antibiotic supply security. With the right policy framework and close coordination with European partners, we can rebuild domestic capacity, strengthen allied production, and secure essential medicines for the long term.
Leadership of the House Select Committee on the CCP is convinced China is stealing American AI models. That’s why China has an OpenAI rival, called DeepSeek, and the Europeans have nothing.
The findings reinforce a persistent pattern in global solar trade: when enforcement actions target specific countries, production and shipments shift to new jurisdictions.
As the Congressional Budget Office (CBO) projects a $1.9 trillion federal deficit for fiscal year 2026, Congress is under increasing pressure to identify durable budget pay-fors. In most cases, that discussion quickly narrows to three familiar choices: raise domestic taxes, cut spending, or continue borrowing more. But tariffs warrant more serious consideration.
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
Revoking PNTR for China would move Chinese imports onto an average effective Column 2 tariff rate of 38.9 percent, helping rebalance trade, restore domestic production capacity, and reduce strategic dependence on an increasingly adversarial economic system.